DOCSLIB.ORG

THE DEVELOPMENT of a PURIFICATION METHOD of LITHIUM by J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
THE DEVELOPMENT of a PURIFICATION METHOD of LITHIUM by J PURIFICATION METHOD OF LITHIUM 1 lilPAUWELeS an d K. F. LAUER Çî'ljl·1«*, Joint Nuclear Research Center Geel Establishment - Belgium Central Bureau for Nuclear Measurements - CBNM m rth ·«·>·»· TJ ΪΓ tfl " ■ imp Γ|ί*Γ ¡fö'ffltl i »'rtrtpít Β 111 iWMVWjtK'1* i » *.ΗΙΗ i rt»1»*' ·1 fittili rwi : : ij iff-» lii LEGAL NOTICE »h>'<t m This document was prepared under the sponsorship of the Commission of the European Communities. Neither the Commission of the European Communities, its m contractors nor any person acting on their behalf : W- WSW S Make any warranty or representation, express or implied, with ι»: respect to the accuracy, completeness, or usefulness of the information contained in this document, or that the use of any information, apparatus, method, or process disclosed in this document may not infringe privately owned rights ; or Assume any liability with respect to the use of, or for damages resulting from the use of any information, apparatus, method or process disclosed in this document. illiiliïitt ..SMID«'liJTma»ÉiP! i \mm n >>:ύ ÙM fer ¡a i WhTvil'îτΊ!-filt» flKwkk »rûiUJI »¡¿rtlüUCUB·'!!·'LkS*í'·7a*»iPVTι w This report is on sale at the addresses listed on cover npage .4 the price of FF 4 BP MW ¡feii'lfâ EUR 4072 e THE DEVELOPMENT OP A PURIFICATION METHOD OF LITHIUM by J. PAUWELS and K.F. LAUER European Atomic Energy Community — EURATOM Joint Nuclear Research Center — Geel Establishment (Belgium) Central Bureau for Nuclear Measurements — CBNM Brussels, September 1968 — 22 Pages — 3 Figures — FB 40 A purification method of lithium on a cation-exchange resin in 1 M HCl was described. To allow the preparation of lithium containing Z. 50 ppm alkali and alkali-earth metals, a special purification of the ion-exchanger was needed. A method using batch operations with the tetra lithium salt of EDTA, with 30 % hydrochloric acid, and elution with 1 M hydrochloric acid was described. EUR 4072 e THE DEVELOPMENT OF A PURIFICATION METHOD OF LITHIUM by J. PAUWELS and K.F. LAUER European Atomic Energy Community — EURATOM Joint Nuclear Research Center — Geel Establishment (Belgium) Central Bureau for Nuclear Measurements — CBNM Brussels, September 1968 — 22 Pages — 3 Figures — FB 40 A purification method of lithium on a cation-exchange resin in 1 M HCl was described. To allow the preparation of lithium containing ^ 50 ppm alkali and alkali-earth metals, a special purification of the ion-exchanger was needed. A method using batch operations with the tetra lithium salt of EDTA, with 30 % hydrochloric acid, and elution with 1 M hydrochloric acid was described. EUR 4072 e THE DEVELOPMENT OF A PURIFICATION METHOD OF LITHIUM by J. PAUWELS and K.F. LAUER European Atomic Energy Community — EURATOM Joint Nuclear Research Center — Geel Establishment (Belgium) Central Bureau for Nuclear Measurements — CBNM Brussels, September 1968 — 22 Pages — 3 Figures — FB 40 A purification method of lithium on a cation-exchange resin in 1 M HCl was described. To allow the preparation of lithium containing Z. 50 ppm alkali and alkali-earth metals, a special purification of the ion-exchanger was needed. A method using batch operations with the tetra lithium salt of EDTA, with 30 % hydrochloric acid, and elution with 1 M hydrochloric acid was described. EUROPEAN ATOMIC ENERGY COMMUNITY - EURATOM THE DEVELOPMENT OF A PURIFICATION METHOD OF LITHIUM by J. PAUWELS and K. F. LAUER 1968 Joint Nuclear Research Center Geel Establishment - Belgium Central Bureau for Nuclear Measurements - CBNM SUMMARY A purification method of lithium on a cation-exchange resin in 1 M HCl was described. To allow the preparation of lithium containing ¿1 50 ppm alkali and alkali-earth metals, a special purification of the ion-exchanger was needed. A method using batch operations with the tetra lithium salt of EDTA, with 30 % hydrochloric acid, and elution with 1 M hydrochloric acid was described. KEYWORDS REFINING IMPURITIES SEPARATION PROCESSES LITHIUM ION EXCHANGE MATERIALS EDTA HYDROCHLORIC ACID - 3 Contents page 1. Introduction 1 2. Principle of the method 2 3. Experimental details of the method 2 3. 1. Elements of interest and their determination 2 3.2. Determination of distribution coefficiente 2 3.3. Determination of purification factors (PF) 4 3.4. Purification of AG 50W-XI6 5 4. Results and conclusion 7 References 9 5 - 1. Introduction In a previous report, four methods of determination of 0. 1 M lithium hydroxide solutions with a final accuracy of 0.02% were described . As these methods, which are not selec- ri 7 tive, have to be applied to Li and Li solutions for the pre­ paration of isotopie blends, and no chemically pure Li or 7 Li samples were available, a purification method of lithium was needed. The purity of the final lithium has to be such, that the resi­ dual impurities do not cause any hygroscopy that might dis­ turb gravimetry of the formed lithium salts, and that cor­ rections for systematic errors are practically negligible. Further, the lithium has to be in such a form that its trans­ formation into a pure 0. 1 M aqueous hydroxide solution is possible. L η The most important impurities found in enriched Li or Li samples were alkali- and alkali-earth metals (up to 0. 15% together). Different separations of lithium from these elements were reported earlier, but they were mostly limited to one or two elements, and few authors give indications about the absolute purity of the separated lithium fraction. Most of (2-6^ these methods are based on extraction , precipitation (7-12) , . (13-35) x , or ion exchange chromatography Nevertheless, the most recent of them all concern separa­ tions on cation exchange resins in the hydrogen form. An presencimportane t ostudf Dowey ofx th5e0 anbehavioud Duolitr e ofC 3th ei n alkalthe isyste metalm s HClin · v(35) H90 - CH OH was done by Nelson '. The described s paration method is based on this work. - 6 2. Principle of the Method In diluted hydrochloric acid the alkali metals are rather strongly absorbed by cation-exchanger s like Dowex 50, whereby lithium is the least absorbed one. From the values (35) of the distribution coefficients as determined by Nelson for Dowex-X4 it can be seen that quantitative separations must be possible. To obtain still higher selectivities it is useful to use a resin with a higher DVB-content ("X16"). The described purification was performed on AG 50W-X16 (50/100 mesh), a Dowex 50W-X16 specially purified for ana­ lytical purposes. Nevertheless, further purification of this resin was necessary. This was made by batch operations withE.D.T.A. in Li OH medium, concentrated hydrochloric acid and final elution with 1 M hydrochloric acid. 3. Experimental Details of the Method 3.1. Elements of interest and their determination 3.1.1. Lithium Lithium was localized in the eluate and determined for the calculation of the distribution coefficients by transformation into and calcination as sulfate. In the case of the Κ,-determinations 5 ml fractions containing 7 to 15 mg of lithium sulfate were analysed. Under these con­ ditions a precision of 1-2% can be obtained. 3.1.2. Sodium, potassium, beryllium, magnesium and calcium During the determination of distribution coefficients and purification factors, these elements were determined rela- tively by tracing them with Na, K, Be, " Mg and Ca. The first four isotopes were measured by integral γ -counting 45 with a Nal(Tl) Well-type scintillation counter, Ca by rela­ tive β -counting. During the separation test Li/Mg, mag­ nesium was determined photometrically with titan yellow. 3.1.3. Trace analysis in ion-exchangers and purified lithiums Ion-exchangers were calcined and purified lithiums dried as lithium chloride. The residues were analysed for metal­ lic impurities by the emission spectrographic service of the C.B.N.M. 3.2. Determination of distribution coefficients (Κ ,) Distribution coefficients for lithium, sodium, potassium, beryllium, magnesium and calcium were determined for com­ mercial grade Dowex50W-Xl6 by batch equilibration tests on 1-2 grams oven dried resin and 10 ml of hydrochloric acid. Κ ..-values were calculated from relative measurements of α identical fractions of blanks and samples using the formula: M -M ml Κ d M1 g in which: M. = the total amount of the ion t M, = the amount present in the liquid ml = the number of milliliters of hydrochloric acid. g= the number of grams of oven-dried resin. A summary of the obtained results is given in figure 1. Separation factors β = Κ, /Κ are summarized in figure 2. M Li From this figure it can be seen that an efficient separation (β > 2) can be expected between 0. 5 and 2 M hydrochloric acid. To avoid contamination of the separated lithium by trace im­ purities contained in the ion-exchanger, it is important that the Κj-values of the elements to be separated are large, but a too - 8 large K,-value for lithium leads to broadening of the lithium peak in the effluent. 1 M hydrochloric acid was chosen as eluant. The K,- and ß-values derived from figures 1 and 2 for this medium were summarized in Table I. 3. 3. Determination of purification factors (P. F. ) 3.3.1. Method of separation Separations were performed on 3 cm diameter quartz columns filled with a quantity of resin equivalent to 80 grams of oven- dried Dowex 50W-X16 ( «400 meq.). Before the separation begins the resin is washed with bidistilled water, until chloride ions are fully removed. On the other hand 0.5 g of lithium and 100 to 500 /Ug of a traced alkali- or alkali earth metal are absorbed on 16 gram oven- dried Dowex 50W-X16 («80 meq.) by mixing during 30 minutes.
Load more

Recommended publications
  • SAFETY DATA SHEET Electrolyte Licl 1 Mol/L in Ethanol
    SAFETY DATA SHEET according to Regulation (EU) No. 453/2010 Electrolyte LiCl 1 mol/l in ethanol 1. Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product code 51350088, 51343183 Synonyms None. 1.2. Relevant identified uses of the substance or mixture and uses advised against Use of the Laboratory chemicals Substance/Preparation 1.3. Details of the supplier of the safety data sheet Company/Undertaking Mettler-Toledo AG Identification ANALYTICAL Sonnenbergstrasse 74 CH-8603 Schwerzenbach Schweiz Tel: +41-44-806-77-11 Fax: +41-44-806-73-50 Email: [email protected] 1.4. Emergency telephone +41-44-251 51 51 (Tox Center) number Revision Date 07.03.2014 Version GHS 1 2. Hazards identification 2.1. Classification of the substance or mixture Electrolyte LiCl 1 mol/l in ethanol (9830) V. GHS 1 / 07.03.2014 Print Date 28.03.2014 Page 1/10 Classification according to Flammable liquids, Cat. 2, H225 Regulation (EC) No. 1272/2008 (GHS/CLP) The product is classified and labelled according to Regulation (EC) No. 1272/2008 (GHS/CLP). Classification according to EU F; R11 Directives 67/548/EEC or 1999/45/EC Additional information For the full text of the phrases mentioned in this Section, see Section 16. 2.2. Label elements F Signal Word Danger Hazard Statements H225: Highly flammable liquid and vapour. Precautionary statements P210b: Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P243: Take precautionary measures against static discharge. P280: Wear protective gloves/ protective clothing/ eye protection/ face protection.
    [Show full text]
  • Separation of Water out of Highly Concentrated Electrolyte Solutions Using Multistage Vacuum Membrane Distillation
    Separation of water out of highly concentrated electrolyte solutions using multistage vacuum membrane distillation Bin Jiang Master of Science Thesis KTH School of Industrial Engineering and Management Energy Technology EGI-2013-082MSC EKV967 Division of Heat and Power SE-100 44 STOCKHOLM Master of Science Thesis EGI-2013-082MSC EKV967 Separation of water out of highly concentrated electrolyte solutions using multistage vacuum membrane distillation Bin Jiang Approved Examiner Supervisor 26.09.2013 Andrew Martin Daniel Minilu Woldemariam Commissioner Contact person Abstract Absorption dehumidification requires regeneration system to regenerate diluted desiccant solutions, which are still highly concentrated. A novel multi-stage vacuum membrane distillation system was applied for separating water out of the highly concentrated solution. The performance of this novel membrane distillation system with high concentration solution is studied, as well as the effect of solution concentration, heating temperature and feed flow rate on concentration increase, permeate flux and specific energy consumption was studied. Feed solutions are LiCl solution (22-30 wt%) and CH3COOK solution (50-60 wt%).Other experimental parameters studied were: heating temperature, 70-80 °C, feed flow rate, 1.2-2.0 l/min. Response surface method is applied for model building, in order to provide a better understanding of the interactions between different parameters. Compared with pure water, high concentration solution has lower vapor pressure, which leads to lower permeate flux. The highest concentration the system can reach is 36.5 wt% for LiCl solution and over 70 wt% for CH3COOK solution, when the heating temperature is 80 °C. Lower concentration and higher heating temperature will result in larger increase in concentration, higher permeate flux and also lower specific energy consumption.
    [Show full text]
  • A Study of Lithium Precursors on Nanoparticle Quality
    Electronic Supplementary Material (ESI) for Nanoscale. This journal is © The Royal Society of Chemistry 2021 Electronic Supplementary Information Elucidating the role of precursors in synthesizing single crystalline lithium niobate nanomaterials: A study of lithium precursors on nanoparticle quality Rana Faryad Ali, Byron D. Gates* Department of Chemistry and 4D LABS, Simon Fraser University, 8888 University Drive Burnaby, BC, V5A 1S6, Canada * E-mail: [email protected] This work was supported in part by the Natural Sciences and Engineering Research Council of Canada (NSERC; Grant No. RGPIN-2020-06522), and through the Collaborative Health Research Projects (CHRP) Partnership Program supported in part by the Canadian Institutes of Health Research (Grant No. 134742) and the Natural Science Engineering Research Council of Canada (Grant No. CHRP 462260), the Canada Research Chairs Program (B.D. Gates, Grant No. 950-215846), CMC Microsystems (MNT Grant No. 6345), and a Graduate Fellowship (Rana Faryad Ali) from Simon Fraser University. This work made use of 4D LABS (www.4dlabs.com) and the Center for Soft Materials shared facilities supported by the Canada Foundation for Innovation (CFI), British Columbia Knowledge Development Fund (BCKDF), Western Economic Diversification Canada, and Simon Fraser University. S1 Experimental Materials and supplies All chemicals were of analytical grade and were used as received without further purification. Niobium ethoxide [Nb(OC2H5)5, >90%] was obtained from Gelest Inc., and benzyl alcohol (C7H7OH, 99%) and triethylamine [N(C2H5)3, 99.0%] were purchased from Acros Organics and Anachemia, respectively. Lithium chloride (LiCl, ~99.0%) was obtained from BDH Chemicals, and lithium bromide (LiBr, ≥99.0%), lithium fluoride (LiF, ~99.9%), and lithium iodide (LiI, 99.0%) were purchased from Sigma Aldrich.
    [Show full text]
  • Lithium Sulfate
    SIGMA-ALDRICH sigma-aldrich.com Material Safety Data Sheet Version 4.1 Revision Date 09/14/2012 Print Date 03/12/2014 1. PRODUCT AND COMPANY IDENTIFICATION Product name : Lithium sulfate Product Number : 203653 Brand : Aldrich Supplier : Sigma-Aldrich 3050 Spruce Street SAINT LOUIS MO 63103 USA Telephone : +1 800-325-5832 Fax : +1 800-325-5052 Emergency Phone # (For : (314) 776-6555 both supplier and manufacturer) Preparation Information : Sigma-Aldrich Corporation Product Safety - Americas Region 1-800-521-8956 2. HAZARDS IDENTIFICATION Emergency Overview OSHA Hazards Target Organ Effect, Harmful by ingestion. Target Organs Central nervous system, Kidney, Cardiovascular system. GHS Classification Acute toxicity, Oral (Category 4) GHS Label elements, including precautionary statements Pictogram Signal word Warning Hazard statement(s) H302 Harmful if swallowed. Precautionary none statement(s) HMIS Classification Health hazard: 1 Chronic Health Hazard: * Flammability: 0 Physical hazards: 0 NFPA Rating Health hazard: 1 Fire: 0 Reactivity Hazard: 0 Potential Health Effects Inhalation May be harmful if inhaled. May cause respiratory tract irritation. Aldrich - 203653 Page 1 of 7 Skin Harmful if absorbed through skin. May cause skin irritation. Eyes May cause eye irritation. Ingestion Harmful if swallowed. 3. COMPOSITION/INFORMATION ON INGREDIENTS Formula : Li2O4S Molecular Weight : 109.94 g/mol Component Concentration Lithium sulphate CAS-No. 10377-48-7 - EC-No. 233-820-4 4. FIRST AID MEASURES General advice Move out of dangerous area.Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2005/0158383 A1 B0ehm Et Al
    US 2005O158383A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0158383 A1 B0ehm et al. (43) Pub. Date: Jul. 21, 2005 (54) QUETIAPINE FORMULATIONS (52) U.S. Cl. ..................... 424/468; 424/484; 514/211.13 (76) Inventors: Garth Boehm, Westfield, NJ (US); Josephine Dundon, Fanwood, NJ (US) (57) ABSTRACT Correspondence Address: CANTOR COLBURN, LLP 55 GRIFFINROAD SOUTH The invention provides novel dosage forms of quetiapine BLOOMFIELD, CT 06002 and its Salts, particularly quetiapine hemifumarate including wax dosage forms, preSS-coat dosage forms, and Sprinkle (21) Appl. No.: 10/970,850 dosage forms, and other novel dosage forms. The invention (22) Filed: Oct. 21, 2004 also provides Sustained release and pulsed release dosage forms of quetiapine and its Salts. Related U.S. Application Data Methods of making novel quetiapine dosage forms are (60) Provisional application No. 60/513,461, filed on Oct. given. 21, 2003. Methods of treating Schizophenia and other neuropsychiatric Publication Classification disorders by administering an effective amount of the dosage forms disclosed herein, either alone or in combination with 51) Int.nt. Cl.C.7 ......................... A61K 3.11554; A61K 9/48 one or more other medicaments, are also provided by the A61K 9/22; A61K 9/14 invention US 2005/0158383 A1 Jul. 21, 2005 QUETIAPINE FORMULATIONS Also, the dosage form can be undesirably large when quetiapine is combined with other active agents, especially CROSS-REFERENCE TO RELATED other high dose active agents. The large Size of these dosage APPLICATION forms can be difficult for patients, especially elderly patients, to Swallow. Further, large dosage form Size may 0001.
    [Show full text]
  • Lithium Sulfate, Technical Grade, Min. 99.0 %
    TECHNICAL DATA SHEET Date of Issue: 2018/02/15 Lithium Sulfate, technical grade, min. 99.0 % CAS-No. 10377-48-7 EC-No. 233-820-4 REACH No. 01-2119968668-14 Molecular Formula Li2O4S Product Number 401142 APPLICATION Additive for manufacturing special glass mixtures. Used for marking of chemical products. Additive in the building material industry. SPECIFICATION Li2SO4 min 99.0 % H2O (105 °C) max. 0.4 % Na max. 0.1 % K max. 0.05 % Fe max. 0.002 % Mg max. 0.01 % Heavy metals (as Pb) max. 0.004 % PHYSICAL PROPERTIES Appearance crystalline Color colorless to white Melting point/ range 860 °C Density 2.2 g/cm3 at 20 °C Bulk density ca. 800 kg/m3 Water solubility 342 g/L at 25 °C The information presented herein is believed to be accurate and reliable, but is presented without guarantee or responsibility on the part of Albemarle Corporation and its subsidiaries and affiliates. It is the responsibility of the user to comply with all applicable laws and regulations and to provide for a safe workplace. The user should consider any health or safety hazards or information contained herein only as a guide, and should take those precautions which are necessary or prudent to instruct employees and to develop work practice procedures in order to promote a safe work environment. Further, nothing contained herein shall be taken as an inducement or recommendation to manufacture or use any of the herein materials or processes in violation of existing or future patent. Technical data sheets may change frequently. You can download the latest version from our website www.albemarle-lithium.com.
    [Show full text]
  • Disease-Modifying Properties of Long-Term Lithium Treatment for Amnestic Mild Cognitive Impairment: Randomised Controlled Trial{ Orestes V
    The British Journal of Psychiatry (2011) 198, 351–356. doi: 10.1192/bjp.bp.110.080044 Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial{ Orestes V. Forlenza, Breno S. Diniz, Ma´ rcia Radanovic, Franklin S. Santos, Leda L. Talib and Wagner F. Gattaz Background Two recent clinical studies support the feasibility of trials biomarkers (amyloid-beta peptide (Ab42), total tau (T-tau), to evaluate the disease-modifying properties of lithium in phosphorylated-tau) (P-tau). Trial registration: NCT01055392. Alzheimer’s disease, although no benefits were obtained from short-term treatment. Results Lithium treatment was associated with a significant decrease in CSF concentrations of P-tau (P = 0.03) and Aims better perform-ance on the cognitive subscale of the To evaluate the effect of long-term lithium treatment on Alzheimer’s Disease Assessment Scale and in attention tasks. cognitive and biological outcomes in people with amnestic Overall tolerability of lithium was good and the adherence mild cognitive impairment (aMCI). rate was 91%. Conclusions Method The present data support the notion that lithium has Forty-five participants with aMCI were randomised to receive disease-modifying properties with potential clinical lithium (0.25–0.5 mmol/l) (n = 24) or placebo (n = 21) in a implications in the prevention of Alzheimer’s disease. 12-month, double-blind trial. Primary outcome measures were the modification of cognitive and functional test Declaration of interest scores, and concentrations of cerebrospinal fluid (CSF) None. Lithium salts have been extensively used in the past decades for safe. Nevertheless, no cognitive benefits were observed among the treatment of bipolar disorder and major depression.
    [Show full text]
  • Introduction Part I. Electrolysis of Lithium Chloride in Pyridine
    DECOMPOSITION CURVES OF LITHIUM CHLORIDE IN PYRIDINE AND IN ACETONE-.'I"E EFFECT OF WATER BY HARRISON EASTMAN PATTEN AND WILLIAM ROY MOTV Introduction Lithium chloride is soluble in a number of organic liquids, and thus affords ready means for studying the effect of change in solvent upon the process of electrolysis. In the deposition of lithium from its chloride in a series of alcohols' we have considered only a simple solvent. This paper takes account of the influence of moisture on the electrolysis of lithium chloride in pyridine and in acetone, starting with the anhy- drous solvents. Part I. Electrolysis of Lithium Chloride in Pyridine During the electrolysis of a pyridine solution of lithium chloride in an open cell,s there is a marked increase in the cell resistance. Thus, in a series of decomposition-curve determinations, polarization values for the total cell ranged from 4.00' volts4 to 2.70 volts, and in sonie instances a rise of ten to a hundred fold was observed in the cell resistance. A preliminary attempt to take anode and cathode curves gave a polarization of 1.6 volts at the anode, and $0.4 volt at the cathode. As these solutions were not strictly anhydrous, it seemed advisable to study the effect of water. So several solutions were made up with great care to exclude moisture, This work was carried out in the laboratories of physical chemistry and of applied electrochemistry at the University of Wisconsin, and the authors wish to express their appreciation of the courtesy extended to them by Professor I,.
    [Show full text]
  • Vapor-Liquid Equilibrium Data for the System Acetone-Methanol Saturated with Salts"
    VAPOR-LIQUID EQUILIBRIUM DATA FOR THE SYSTEM ACETONE-METHANOL SATURATED WITH SALTS" SHUZO OHE, KIMIHIKO YOKOYAMA, AND SHOICHI NAKAMURA Ishikazvajima-Harima Heavy Industries Co., Ltd. Research Institute, Yokohama Vapor-liquid equilibrium data at atmospheric pressure of the system : acetone-methanol-salt are studied. The Salts, Kl, NaCI, MgCI2, CaCI2/ LiCI, and CaBr2 are examined to observe the salt effect on the acetone-methanol system. Effective salts are CaQ2, LiC! and CaBr2, which are more soluble in methanol than Kl, NaCI and MgCh. CaCI2, LiCI and CaBr2 are observed to shift the azeotropic composition from 8O.I to 88.6, 9I-O and 94.O mole /# of acetone, respectively. The salt effect at each infinite dilute concentration of acetone and methanol increases with the increasing solubility of each salt in the rich concentration component. In general, salts shift azeotropic compositions or 2) Experimental method eliminate azeotropes. For example, sodium chloride The salt, being completely non-volatile, appears only saturated in ethanol-water system shifts the azeotropic in the liquid, hence yielding a system consisting of composition from 87 to over 90 mole %ethanol45 and a two-componentvapor phase and a three-component calcium chloride saturated in the ethanol-water system liquid phase. The concentrations of acetone and eliminates the azeotrope25. This salt effect may be used for the separation of azeotropic mixtures. Systems which contain water as one component have been well studied5>9>10), but studies on non-aqueous systems are scarce from the point of salt effect. L. Belcku studied the effect of calcium chloride on the acetone-methanol system and reported on a constant concentration of 2.3 moles of salt/mole of solution.
    [Show full text]
  • Disease-Modifying Properties of Long-Term Lithium Treatment for Amnestic Mild Cognitive Impairment: Randomised Controlled Trial{ Orestes V
    The British Journal of Psychiatry (2011) 198, 351–356. doi: 10.1192/bjp.bp.110.080044 Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial{ Orestes V. Forlenza, Breno S. Diniz, Ma´ rcia Radanovic, Franklin S. Santos, Leda L. Talib and Wagner F. Gattaz Background Two recent clinical studies support the feasibility of trials biomarkers (amyloid-beta peptide (Ab42), total tau (T-tau), to evaluate the disease-modifying properties of lithium in phosphorylated-tau) (P-tau). Trial registration: NCT01055392. Alzheimer’s disease, although no benefits were obtained from short-term treatment. Results Lithium treatment was associated with a significant decrease in CSF concentrations of P-tau (P = 0.03) and Aims better perform-ance on the cognitive subscale of the To evaluate the effect of long-term lithium treatment on Alzheimer’s Disease Assessment Scale and in attention tasks. cognitive and biological outcomes in people with amnestic Overall tolerability of lithium was good and the adherence mild cognitive impairment (aMCI). rate was 91%. Conclusions Method The present data support the notion that lithium has Forty-five participants with aMCI were randomised to receive disease-modifying properties with potential clinical lithium (0.25–0.5 mmol/l) (n = 24) or placebo (n = 21) in a implications in the prevention of Alzheimer’s disease. 12-month, double-blind trial. Primary outcome measures were the modification of cognitive and functional test Declaration of interest scores, and concentrations of cerebrospinal fluid (CSF) None. Lithium salts have been extensively used in the past decades for safe. Nevertheless, no cognitive benefits were observed among the treatment of bipolar disorder and major depression.
    [Show full text]
  • The Use of Lithium to Prevent Or Mitigate Alkali-Silica Reaction in Concrete Pavements and Structures
    The Use of Lithium to Prevent or Mitigate Alkali-Silica Reaction in Concrete Pavements and Structures PUBLIcatION NO. FHWA-HRT-06-133 MARCH 2007 Research, Development, and Technology Turner-Fairbank Highway Research Center 6300 Georgetown Pike McLean, VA 22101-2296 Foreword Progress is being made in efforts to combat alkali-silica reaction in portland cement concrete structures—both new and existing. This facts book provides a brief overview of laboratory and field research performed that focuses on the use of lithium compounds as either an admixture in new concrete or as a treatment of existing structures. This document is intended to provide practitioners with the necessary information and guidance to test, specify, and use lithium compounds in new concrete construction, as well as in repair and service life extension applications. This report will be of interest to engineers, contractors, and others involved in the design and specification of new concrete, as well as those involved in mitigation of the damaging effects of alkali-silica reaction in existing concrete structures. Gary L. Henderson, P.E. Director, Office of Infrastructure Research and Development Notice This document is disseminated under the sponsorship of the U.S. Department of Transportation in the interest of information exchange. The U.S. Government assumes no liability for its contents or use thereof. This report does not constitute a standard, specification, or regulation. The U.S. Government does not endorse products or manufacturers. Trade or manufacturers’ names appear herein only because they are considered essential to the objective of this manual. Quality Assurance Statement The Federal Highway Administration (FHWA) provides high-quality information to serve Government, industry, and the public in a manner that promotes public understanding.
    [Show full text]
  • Investigating Cell Type Specific Mechanisms Contributing to Acute Oral Toxicity
    Prieto et al.: Investigating cell type specific mechanisms contributing to acute oral toxicity Supplementary Data1 Tab. S1: Overview of collected information on specific target organ/system and general cytotoxicity for chemicals correctly assigned to the CLP acute oral toxicity category by the 3T3 NRU cytotoxicity assay General Nervous Cardiovascular GI Chemical Liver Lung Blood Kidney cytotoxicity system system system (±)-Propranolol hydrochloride x ax (4-Ammonio-m-tolyl)ethyl(2- x x hydroxyethyl)ammonium sulfate 1,2,4-Trichlorobenzene x x 1,2-Dichlorobenzene x x 2,4,6- x x Tris(dimethylaminomethyl)phenol 2,4-Dichlorophenoxyacetic acid x x x 5,5-Diphenylhydantoin x x 5-Fluorouracil x x x x Acetophenone x Acetylsalicylic acid x x x x x x Acrolein x x Acrylamide x x x Ammonium chloride x ax ax Atropine sulfate monohydrate x x Benzaldehyde x x Cadmium (III) chloride x x x x x Caffeine x x x Chloroform x x ax x x x x Chloroquine bis(phosphate) x x Chlorpromazine x x x Codeine x x x x Colchicine x x x x Copper sulfate x x x Cupric sulfate pentahydrate x x Cyclosporin A x x x x Diazepam x Diphenhydramine hydrochloride x x Disopyramide x x Ethyl chloroacetate x x Ferrous sulfate x x x Glufosinate-ammonium x Glutethimide x ax x Hexachlorophene x x Lithium carbonate x x x Lithium sulfate x x x Malathion x x Maleic acid x x Meprobamate x x Orphenadrine hydrochloride x x x x p-Benzoquinone x x x Phenol x x x x x Procainamide hydrochloride x x x Quinidine sulfate dehydrate x x x doi:10.14573/altex.1805181s2 ALTEX 36(1), SUPPLEMENTARY DATA 1 General Nervous Cardiovascular GI Chemical Liver Lung Blood Kidney cytotoxicity system system system Resorcinol x x Rifampicin x x Sodium Cyanate x x Sodium oxalate x x x Sodium valproate x bx x x Thioridazine hydrochloride x x Valproic acid x x x x x GI: Gastrointestinal; CLP: Classification, labelling and packaging; NRU: Neutral Red Uptake; a Indirect effect: b chronic effect Tab.
    [Show full text]